- Home
- ELDN vs OGI Comparison
ELDN vs OGI Comparison
Compare ELDN & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- OGI
- Stock Information
- Founded
- ELDN 2004
- OGI 2013
- Country
- ELDN United States
- OGI Canada
- Employees
- ELDN N/A
- OGI N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- ELDN Health Care
- OGI Health Care
- Exchange
- ELDN Nasdaq
- OGI Nasdaq
- Market Cap
- ELDN 178.4M
- OGI 186.1M
- IPO Year
- ELDN N/A
- OGI N/A
- Fundamental
- Price
- ELDN $3.67
- OGI $1.55
- Analyst Decision
- ELDN Strong Buy
- OGI
- Analyst Count
- ELDN 2
- OGI 0
- Target Price
- ELDN $12.50
- OGI N/A
- AVG Volume (30 Days)
- ELDN 849.2K
- OGI 596.4K
- Earning Date
- ELDN 08-18-2025
- OGI 08-12-2025
- Dividend Yield
- ELDN N/A
- OGI N/A
- EPS Growth
- ELDN N/A
- OGI N/A
- EPS
- ELDN N/A
- OGI 0.10
- Revenue
- ELDN N/A
- OGI $135,031,829.00
- Revenue This Year
- ELDN N/A
- OGI $50.30
- Revenue Next Year
- ELDN N/A
- OGI $16.01
- P/E Ratio
- ELDN N/A
- OGI $15.20
- Revenue Growth
- ELDN N/A
- OGI 20.49
- 52 Week Low
- ELDN $2.38
- OGI $0.85
- 52 Week High
- ELDN $5.54
- OGI $2.08
- Technical
- Relative Strength Index (RSI)
- ELDN 67.56
- OGI 65.15
- Support Level
- ELDN $3.64
- OGI $1.43
- Resistance Level
- ELDN $3.93
- OGI $1.49
- Average True Range (ATR)
- ELDN 0.23
- OGI 0.06
- MACD
- ELDN 0.05
- OGI 0.01
- Stochastic Oscillator
- ELDN 71.91
- OGI 95.83
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.